# Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients

> **NCT03117569** · PHASE3 · COMPLETED · sponsor: **Kirby Institute** · enrollment: 380 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** glecaprevir (300mg)/pibrentasvir (120mg)

## Key facts

- **NCT ID:** NCT03117569
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-21
- **Primary completion:** 2018-12-19
- **Final completion:** 2018-12-19
- **Target enrollment:** 380 (ACTUAL)
- **Last updated:** 2019-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03117569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03117569, "Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03117569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*